> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bill Introduced on Generic Drug Prompt Approvals
- URL: https://www.fdaweb.com/bill-introduced-on-generic-drug-prompt-approvals/
- Published: 2024-09-18T12:00:00.000Z
- Updated: 2026-09-14T14:41:37.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5157807

Congresswoman **Nanette Barragán** (D-CA) has reintroduced the *Prompt Approval of Safe Generic Drugs Act,* legislation that would expand access to lower-cost generic drugs by removing hurdles in the drug approval process. “These barriers otherwise prevent the Food and Drug Administration (FDA) from approving certain follow-on products that could improve competition and patient access,” she says in a news release.

“Abuse of the drug approval process by drug manufacturers, such as preventing FDA’s ability to approve generic competitors, has been one of the driving factors behind the rapidly rising cost of prescription drugs,” she says. The legislation would allow generic drugs to enter the market sooner and increase competition, she says.

The measure was [previously introduced](https://www.congress.gov/bill/117th-congress/house-bill/2831/text?s=3&r=2&q=%7B%22search%22%3A%22%5C%22To+amend+the+Federal+Food%2C+Drug%2C+and+Cosmetic+Act+to+provide+for+the+prompt+approval+of+drugs+when+safety+information+is+added+to+labeling%2C+and+for+other+purposes%5C%22%22%7D&ref=fdaweb.com) in 2021\. The text of the current bill has not been posted yet, but a summary of the previous bill says that an ANDA “shall not be ineligible for approval solely because the drug's labeling omits safety information that is protected under another drug's exclusivity protections. Similarly, a drug that is approved under this bill shall not be considered mislabeled for lacking such safety information.”